Gapping up
In reaction to strong earnings/guidance: SWHC +10.2%, BV +8.2%, THRM
+6.4%, XRM +6.2%, AVAV +6.1%, VEEV +3.8%, NYMT +3%, HON +2.5%, (ticking
higher), INXN +2.2%, (light volume), YY +2.1%, IRG +1.9% (light volume),
CKEC +1.7%, (light volume).
M&A news: LO +0.4% / RAI +0.2% (continued strength with ongoing M&A
speculation).
Battery related names seeing continued momentum: FCEL +22.2%, BLDP +12.6%
(announces that 4,935,600 warrants to purchase shares have been exercised,
generating proceeds of ~$7.6 mln), CBAK +3.2% (ticking higher), KNDI +3%,
PLUG +2.5%, TSLA +0.5% (higher despite Peugot SA winning 'Car of the
Year' award).
China related internet names trading higher boosted by YY
results: QIHU +2.5% (Qihoo 360 Tech.'s mobile app content returns to
Apple's (AAPL) China App Store, according to Marbridge), DANG +2.3%
(Dangdang and Yhd.com Form Strategic Partnership), YOKU +1.2%
Other news: STRI +14.9% (continued strength following yesterday's Dutch
tender offer results), NAVB +9.9% (announces acceptance for review of an
additional sNDA to further expand Lymphoseek labeling), ROSG +7.8%
(continued strength following yesterday's 26%+ move higher), ARO +6.5%
(light volume, still looking around for catalyst), LIVE +4.4% (continued
strength), ZNGA +2.7% (continued strength), GOLD +2.6% (still checking),
ARGS +2.4% (presents new data from clinical research for AGS-004
patient-specific immunotherapy in treatment of HIV), HTWR +2.4% (following
THOR news), ACI +2% (Arch Coal sells Hazard thermal mining complex to
Blackhawk for $26.3 mln in cash), JCP +1.9% (still checking), XXIA +1.7%
(announces completion of Audit Committee internal investigation, SEC
filings update, and CFO transition), GLUU +1.7% (continued strength), RGR
+1.6% (following SWHC results), SNTA +0.8% (Synta Pharma has determined
that it will not be presenting at the Cowen Healthcare Conference on March
5 or at ROTH Conference on March 10), PCAR +0.4% (following late
volatility on Class 8 trucking data), .
Analyst comments: ARWR +12.6% (initiated with a Outperform at RBC Capital
Mkts; initiated with a Buy at Deutsche Bank), FMI +2.8% (Foundation
Medicine initiated with Outperform at Wedbush), CYTK +2.8% (re-initiated
with a Buy at ROTH Capital; tgt $25), GTAT +2.4% ( tgt to $18.50 from
$15.50 at BofA/Merrill), GOLD +2.3% ( upgraded to Buy from Neutral at
Nomura), ERIC +1.1% ( upgraded to Outperform at RBC Capital Mkts; tgt
raised to $16 ), FOXA +0.6% ( upgraded to Outperform from Mkt Perform at
BMO Capital Mkts; tgt raised to $40 from $33), VLY +0.6% (upgraded to
Market Perform from Underperform at Keefe Bruyette), TRMB +0.5% (upgraded
to Overweight from Neutral at JPMorgan)